Abstract
In 1978 the WHO Committee on the Immunology of Leprosy, IMMLEP, defined the development of a prophylactic vaccine against leprosy as an objective of high priority. Ten years later, trials are under way of the approaches they identified, namely, vaccines based on antigenically similar cultivatable mycobacteria, killed Mycobacterium leprae, or of a mixture of killed M. leprae with BCG. This chapter will discuss the rationale for such vaccines, together with the possibility of a second-generation vaccine, based on protective antigens produced either by molecular biology or as synthetic peptides.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Walsh, G. P., Meyers, W. M., Binford, C. H., Gerone, P. J., Wolf, R. H. and Leininger, J. R. (1981). Leprosy — a zoonosis. Lepr. Rev. 52 (Suppl. 1), 77–83
Gormus, B. J., Wolf, R. H., Baskin, G. B., Ohkawa, S., Gerone, P. J., Walsh, G. P., Meyers, W. M., Binford, C. H. and Greer, W. E. (1988). A second sooty mangabey monkey with naturally acquired leprosy: first reported possible monkey-to-monkey transmission. Int. J. Lepr., 56, 61–5
Bloom, B. R. (1983). Rationales for vaccines against leprosy. Int. J. Lepr., 51, 505–9
Ridley, D. S. and Jopling, W. H. (1966). Classification of leprosy according to immunity; a five group system. Int. J. Lepr., 34, 255–73
Nathan, C. F., Kaplan, G., Levis, W. R, Nusrat, A, Witmer, M. D., Sherwin, S. A., Job, C. K., Horowitz, C. R., Steinman, R. M. and Cohn, Z. A. (1986). Local and systemic effects of intradermal recombinant interferon gamma in patients with lepromatous leprosy. N. Engl. J. Med., 315, 6–15
Douvas, G. S., Looker, D. L., Vatter, A. E. and Crowle, A. J. (1985). Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun., 50, 1–8
Godai, T. and Negassi, K. (1973). Subclinical infection in leprosy. Br. Med. J., 2, 557–9
Doull, J. A., Guinto, R. S. and Mabalay, M. C. (1957). Effect of BCG vaccination, lepromin testing and natural causes in inducing reactivity to lepromin and to tuberculin. Int. J. Lepr., 25, 13–37
Shepard, C. C. (1965). Vaccination against experimental infection with Mycobacterium leprae. Am. J. Epidemiol., 81, 150–63
Shepard, C. C. (1976). Vaccination of mice against M. leprae infection. Int. J. Lepr., 44, 222–6
Fine, P. E. M. (1988). BCG vaccination against tuberculosis and leprosy. Br. Med. Bull., 44, 691–703
Lwin, K., Sundaresan, T., Gyi, M. M., Bechelli, L. M., Tamondong, C., Gallego Garbajosa, P., Sansarricq, H. and Noordeen, S. K. (1985). BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. Bull. WHO, 63, 1069–78
Stanley, S. J., Howland, C., Stone, M. M. and Sutherland, I. (1981). BCG vaccination of children against leprosy in Uganda: final results. J. Hyg. (Camb)., 87, 233–48
Ponnighaus, J. M. and Fine, P. E. M. (1986). The Karonga prevention trial — which BCG? Lepr. Rev., 57 (Suppl. 2), 285–92
Shepard, C. C. (1960). The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J. Exp. Med., 112, 445–54
Kirchheimer, W. F. and Storrs, E. E. (1971). Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. 1. Report of lepromatoid leprosy in the experimentally infected armadillo. Int. J. Lepr., 39, 693–702
Smelt, A. H. M., Rees, R. J. W. and Liew, F. Y. (1981). Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin. Exp. Immunol., 44, 501–6
Bechelli, L. M., Haddad, N., Pagnano, P. M. G., Neves, R. G., Melchior, E. and Fregnan, R. C. (1980). Double blind trials to determine the late reactivity of leprosy patients and unaffected persons to different concentrations of armadillo lepromin in comparison to human lepromin. Int. J. Lepr., 48, 126–34
Shepard, C. C., Draper, P, Rees, R J. W. and Lowe, C. (1980). Effect of purification steps on the immunogenicity of Mycobacterium leprae. Br. J. Exp. Pathol., 61, 376–9
Draper, P. (1980). WHO report of the fifth meeting on the immunology of leprosy. Annex 4, WR-MMLEFSWG, (5)80,3, 24-6
Gill, H. K., Mustafa, A. S. and Godai, T. (1986). Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae. Bull. WHO, 64, 121–6
Gill, H. K., Mustafa, A. S. and Godai, T. (1987). In vitro proliferation of lymphocytes from human volunteers vaccinated with armadillo-derived, killed M. leprae. Int. J. Lepr., 55, 30–5
Gill, H. K., Mustafa, A. S, Ivanyi, J, Harboe, M. and Godai, T. (1986). Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae. Lepr. Rev., 57 (Suppl. 2), 293–300
Mustafa, A. S., Gill, H. K., Nerland, A, Britton, W. J., Mehra, V., Bloom, B. R., Young, R. A. and Godal, T. (1986). Human T-cell clones recognise a major M. leprae protein antigen expressed in E. coli. Nature (Lond.), 319, 63–6
Convit, J., Pinardi, M. E., Rodriguez, Ochoa, G., Ulrich, M., Avila, J. L. and Goikmon-Yakr, M. (1974). Elimination of Mycobacterium leprae subsequent to local in vitro activation of macrophages in lepromatous leprosy by other mycobacteria. Clin. Exp. Immunol., 17, 821–6
Convit, J., Ulrich, M., Aranzazu, N., Castellanos, P. L., Pinardi, M. E. and Reyes, O. (1986). The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Lepr. Rev., 57 (Suppl. 2), 263–73
Convit, J., Aranzazu, N., Ulrich, M., Pinardi, M. E., Reyes, O. and Alvarado, J. (1982). Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts. Int. J. Lepr., 50, 415–25
Rada, E. M., Convit, J., Ulrich, M., Gallinotto, M. E. and Aranzazu, N. (1987). Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. Int. J. Lepr., 55, 646–50
Fine, P. E. M., Ponnighaus, J. M., Maine, N., Clarkson, J A. and Bliss, L. (1986). The protective efficiency of BCG against leprosy in Northern Malawi. Lancet, 2, 499–502
Gangal, S. G. and Khanolkar, S. R. (1974). Delayed hypersensitivity in vitro to an acid fast mycobacterium cultivated from human lepromatous leprosy. Indian J. Med. Res., 62, 290–6
Girdhar, B. K. and Desikan, K. V. (1978). Results of skin tests with five different mycobacteria. Lepr. India, 50, 555–9
Deo, M. G., Bapat, C. V., Chullawalla, R. G. and Bhatki, W. S. (1981). Potential anti-leprosy vaccine from killed ICRC bacilli — a clinicopathological study. Indian J. Med. Res., 74, 164–77
Deo, M. G., Bapat, C. V., Bhalerao, V., Chaturvedi, R. M., Bhatki, W. S. and Chullawalla, R. G. (1983). Anti-leprosy potentials of ICRC vaccine: a study in patients and healthy volunteers. Int. J. Lepr., 51, 540–9
Bhatki, W. S. Chulawala, R. G., Bapat, C. V. and Deo, M. G. (1983). Reversal reactions in lepromatous patients induced by a vaccine containing killed ICRC bacilli — a report of five cases. Int. J. Med., 51, 466–72
Chaturvedi, R. M., Chirmule, N. B., Yellapurkar, M. V., Shaikh, S. U. and Deo, M. G. (1987). Effects of ICRC anti leprosy vaccine in healthy subjects. Int. J. Lepr., 55, 657–66
Chirmule, N. B., Chaturvedi, R. M. and Deo, M. G. (1988). Immunogenic ‘subunit’ of the ICRC antileprosy vaccine. Int. J. Lepr., 56, 27–35
Mustafa, A. S. and Talwar, G. P. (1978). Five cultivatable mycobacterial strains giving blast transformation and leukocyte migration inhibition of leukocytes analogous to Mycobacterium leprae. Lepr. India, 50, 498–508
Chaudhuri, S., Fotedar, A. and Talwar, G. P. (1983). Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w. Int. J. Lepr., 51, 159–68
Zaheer, S. A., Talwar, G. P., Walia, R. and Mukherjee, R. (1988). Results of one year of phase H/phase III trials with the candidate antileprosy vaccine Mycobacterium w. Health Cooperation Papers, 9, 245
Hunter, S. W. and Brennan, P. J. (1981). A novel phenolic glycolipid from M. leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol., 147, 728–35
Young, D. B. and Buchanan, T. M. (1983). A serological test for leprosy with a glycolipid specific for M. leprae. Science, 221, 1057–9
Brett, S. J., Lowe, C., Payne, S. N. and Draper, P. (1984). Phenolic glycolipid-1 of Mycobacterium leprae causes non-specific inflammation but has no effect on cell-mediated responses in mice. Infect. Immun., 46, 802–8
Job, C. K., Sanchez, R. M., McCormick, G. T. and Hastings, R. C. (1987). Ability of the phenolic glycolipid-1 antigen of M. leprae to elicit a positive Mitsuda response in the armadillo (Dasypus novemcinctus). Int. J. Lepr., 55, 299–304
Mehra, V., Brennan, P. J., Rada, E., Convit, J. and Bloom, B. R. (1984). Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature, 308, 194–96
Neill, M. A. and Klebanoff, S. J. (1988). The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages. J. Exp. Med., 167, 30–42
Young, R. A., Mehra, V., Sweetser, D., Buchanan, T., Clark-Curtiss, J., Davis, R. W. and Bloom, B. R. (1985). Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature, 316, 450–2
Britton, W. J., Garsia, R. J., Hellqvist, L., Watson, J. D. and Basten, A. (1986). The characterization and immunoreactivity of a 70 kd protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepro. Rev., 57 (Suppl. 2), 67–75
Young, R. A., Bloom, B. R., Grosskinsky, C. M., Ivanyi, J., Thomas, D. and Davis, R. W. (1985). Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc. Natl. Acad. Sci. USA, 82, 2583–7
Cohen, M. L., Mayer, L. W., Rumschlag, H. S., Yakrus, M. A., Jones, W. D. and Good, R. C. (1987). Expression of proteins of Mycobacterium tuberculosis in Escherichia coli and potential of recombinant genes and proteins for development of diagnostic reagents. J. Clin. Microbiol., 25, 1176–80
Young, D. B., Kent, L. and Young, R. A (1987). Screening of a recombinant mycobacterial DNA library with polyclonal antisera and molecular weight analysis of expressed antigens. Infect. Immun., 55, 1421–5
Thole, J. E. R., Dauwerse, H. G., Das, P. K., Groothuis, D. G., Schouls, L. M. and van Embden, J. D. A. (1985). Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect. Immun., 50, 800–6
Lamb, J. R. and Rees, A. D. M. (1988). Antigen specificity and function of human T lymphocyte clones reactive with mycobacteria. Br. Med. Bull., 44, 600–10
Lamb, J. R. and Young, D. B. (1987). A novel approach to the identification of T-cell epitopes in Mycobacterium tuberculosis using T-lymphocyte clones. Immunology, 60, 1–5
Abou-Zeid, C., Filley, E., Steele, J. and Rook, G. A. W. (1987). A simple new method for using antigens separated by Polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J. Immunol. Meth., 98, 5–10
Shinnick, T. M., Sweetser, D., Thole, J, van Embden, J. and Young, R. A. (1987). The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG. Infect. Immun., 55, 1932–5
Buchanan, T. M., Nomaguchi, H., Anderson, D. C., Young, R. A., Gillis, T. P., Britton, W. J., Ivanyi, J., Kolk, A. H. J., Closs, O., Bloom, R. and Mehra, V. (1986). Characterisation of mycobacterial species specificity of 14 separate epitopes which reacted with monoclonal antibodies to the 65,000 molecular weight protein molecule of Mycobacterium leprae., Lepr. Rev., 57 (Suppl. 2), 63–6
Husson, R. N. and Young, R. A. (1987). Genes for the major protein antigens of Mycobacterium tuberculosis: the etiological agents of tuberculosis and leprosy share an immunodominant antigen. Proc. Natl. Acad. Sci. USA, 84, 1679–83
Mehra, V., Sweetser, D., Young, R. A. (1986). Efficient mapping of protein antigenic determinants. Proc. Natl. Acad. Sci. USA, 83, 7013–17
Lamb, J. R., Ivanyi, J., Rees, A. D. M., Rothbard, J. B., Howland, K., Young, R. A. and Young, D. B. (1987). Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO J., 6, 1245–9
Lamb, F. I., Kingston, A. E., Estrada- G. I. and Colston, M. J. (1988). Heterologous expression of the 65-kilodalton antigen of Mycobacterium leprae and murine T-cell responses to the gene product. Infect. Immun., 56, 1237–41
Kaufmann, S. H. E., Vath, U., Thole, J. E. R., van Embden, J. D. A. and Emmrich, F. (1987). Enumeration of T-cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur. J. Immunol., 17, 351–7
Oftung, F., Mustafa, A. S., Husson, R., Young, R. A. and Godai, T. (1987). Human T-cell clones recognise two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli. J. Immunol., 138, 927–31
Emmrich, F., Thole, J., van Embden, J. and Kaufmann, S. H. E. (1986). A recombinant 64 kilodalton protein of Mycobacterium bovis Bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens. J. Exp. Med., 163, 1024–9
Van Schooten, W. C. A., Ottenhoff, T. H. M., Klatser, P. R., Thole, J., de Vries, R. R. P. and Kolk, A. H. J. (1988). T cell epitopes on the 36k and 65k Mycobacterium leprae antigens defined by human T cell clones. Eur. J. Immunol., 18, 849–54
Gillis, T. P., Miller, R. A, Young, D. B, Khanolkar, S. R. and Buchanan, T. M. (1985). Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall. Infect. Immun., 49, 371–7
De Bruyn, J., Bosmans, R., Turner, M., Weckx, M., Nyabenda, J., van Vooren, J.-P., Falmagne, P., Wiker, H. G. and Harboe, M. (1987). Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG. Infect. Immunol., 55, 245–52
Young, D. B., Ivanyi, J., Cox, J. H. and Lamb, J. R. (1987). The 65kDa antigen of mycobacteria — a common bacterial protein? Immunol. Today, 8, 215–19
Young, D., Lathigra, R., Hendrix, R., Sweetser, D. and Young, R.A. (1988). Stress proteins are immune targets in leprosy and tuberculosis. Proc. Natl. Acad. Sci. USA, 85, 4267–70
Booth, R. J., Harris, D. P., Love, J. M. and Watson, J. D. (1988). Antigenic proteins of Mycobacterium leprae. Complete sequence of the gene for the 18kDa protein. J. Immunol., 140, 597–601
Engers, H. D., Bloom, B. R. and Godai, T. (1985). Monoclonal antibodies against mycobacterial antigens. Immunol. Today, 6, 346–8
Hopwood, D. A., Kieser, T., Colston, M. J. and Lamb, F. I. (1988). Molecular biology of mycobacteria. Br. Med. Bull., 44, 528–46
Bloom, B. R. (1986). Learning from leprosy: a perspective on immunology and the third world. J. Immunol., 137, i–x
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R. and Jacobs, W. R. (1988). Lysogeny and transformation in mycobacteria. Stable expression of foreign genes. Proc. Natl. Acad. Sci. USA, 85, 6987–91
Zainuddin, Z. F., Kunza, Z. M. and Dale, J. W. (1989). Transformation of Mycobacterium smegmatis with E. coli plasmids carrying a selectable resistance marker. Molec. Microbiol., 3, 29–34
Klatser, P. R., van Rens, M. M. and Eggelte, T. A. (1984). Immunochemical characterisation of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immuno-peroxidase technique (SGIP) using patients’ sera. Clin. Exp. Immunol., 56, 537–44
Vega-Lopez, F., Stoker, N. G., Locniskar, M. F., Dockrell, H. M., Grant, K. A. and McAdam, K. P. W. J. (1988). Recognition of mycobacterial antigens by sera from patients with leprosy. J. Clin. Microbiol, 26, 2474–9
Rook, G. A. W. (1980). The immunogenicity of killed mycobacteria. Lepr. Rev., 51, 295–301
Rook, G. A. W., Steele, J., Barnass, S., Mace, J. and Stanford, J. L. (1986). Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin. Exp. Immunol., 63, 105–10
Abou-Zeid, C., Smith, I., Grange, J., Steele, J. and Rook, G. (1986). Subdivision of daughter strains of Bacille Calmette-Guerin (BCG) according to secreted protein patterns. J. Gen. Microbiol., 132, 3047–53
Collins, F. M., Lamb, J. R. and Young, D. B. (1988). Biological activity of protein antigens isolated from Mycobacterium tuberculosis culture filtrate. Infect. Immun., 56, 1260–6,
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Dockrell, H.M., McAdam, K.P.W.J. (1989). Immunization against leprosy. In: Zuckerman, A.J. (eds) Recent Developments in Prophylactic Immunization. Immunology and Medicine, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1067-6_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-1067-6_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6969-4
Online ISBN: 978-94-009-1067-6
eBook Packages: Springer Book Archive